Long COVID with dysautonomia, much better after Mestinon and dextromethorphan
- Condition
- Long COVID
- At worst
- Not stated
- Ill before improving or writing
- Not stated
- Last post
- Jun 2026
In their words
- Condition: Long COVID
I’m a cardiologist and I have it.
In context ↗ - Now: Much better
I got substantially better on 0.25 mg of Tirzepatide but that eventually caused me to become depressed.
In context ↗ - Began after: COVID
I’m a cardiologist with LC.
In context ↗
Summary
A cardiologist with long COVID reported being treated successfully with Mestinon and having much success with dextromethorphan as well. In June 2026 they said they had got substantially better on 0.25 mg of tirzepatide, but that it eventually caused depression. They described the illness as long COVID and linked it to dysautonomia.
Ask Miruvor AI
What they tried
What they credit
Their words about each treatment
- Mestinon · Helped a lot
I am being treated successfully with Mestinon.
In context ↗ - dextromethorphan · Helped a lot
I’ve had much success with Mestinon as well as dextromethorphan
In context ↗ - Tirzepatide · Helped a lot
I got substantially better on 0.25 mg of Tirzepatide but that eventually caused me to become depressed.
In context ↗
Approaches: GLP-1 drugs · POTS medication · Other drugs and medicines
Their path
They say too little about how ill they were at each step to draw it on the severity scale, so the steps are listed as they describe them. Dates are when they posted.
| When | What happened | After |
|---|---|---|
| — | long COVIDI’m a cardiologist with LC.In context ↗ | |
| 2025-06-28 | treated successfully for long COVIDI am being treated successfully with Mestinon.In context ↗ | Mestinon / pyridostigmine |
| 2026-06-19 | substantially better on tirzepatide, then became depressedI got substantially better on 0.25 mg of Tirzepatide but that eventually caused me to become depressed.In context ↗ | Tirzepatide (Mounjaro, Zepbound) |
Adverse events
- Tirzepatide (Mounjaro, Zepbound)“I got substantially better on 0.25 mg of Tirzepatide but that eventually caused me to become depressed.” In context ↗ Mood or psychiatric effects
Ask Miruvor AI
Similar stories
-
Not enough detail to draw a path
Nearly bedbound with long COVID, now somewhat better with red light therapy and rest
Fell ill with COVID-19 in March 2020 and worsened over five years to nearly totally bedbound. Pfizer jabs brought remissions of weeks, but overdoing activity during them set them back. Red light therapy from December 2024 and aggressive rest lifted them out…
-
Mostly in bed with ME/CFS, partial gains from LDN and IV fluids then relapses
Trail 92725, in the UK, dated their decline to the first vaccines in early 2021 and was mostly in bed by 2025, on top of long-standing POTS, MCAS and hEDS. LDN, weekly IV fluids, aciclovir, ketotifen and mestinon brought partial gains, but crashes in October…
-
Bedridden with ME/CFS for almost two years, now somewhat better with IVIG
Sandpiper 26983 got long COVID after a COVID infection in September 2023; infections and an endoscopy in early 2024 left them very severe and bedridden for almost two years. LDA, Mestinon and lumbrokinase helped cognition; IVIG, begun May 2025 for autoimmune…
-
Off work with long COVID brain fog and PEM, now much better with medication
A man who got long COVID in April 2022 had brain fog, PEM, pressure headaches and anxiety, and was at worst off work. Guanfacine, higher-dose Effexor with Buspar, Adderall, low-dose naltrexone and low-dose tirzepatide helped, though the naltrexone boost…